Human Ceramide Kinase (Cerk) Elisa Kit, 96Tests
Catalog No :
CAS Number :
Brand :
In Stock
Specifications:
Application | ELISA-Based Assays |
Storage Temperature | 2-8°C |
Product Type | Elisa Kit |
Product Grade | Molecular Biology |
The Human Ceramide Kinase (CERK) ELISA Kit is a sensitive and precise tool designed for the quantitative detection of CERK levels in human serum, plasma, culture media, and other biological fluids. Using a Sandwich-ELISA technique, this kit is ideal for research in lipid signaling, ceramide metabolism, and related biological processes.
Purpose
- Quantification of CERK Levels:
- Measures CERK concentrations as a biomarker for ceramide metabolism and signaling pathways.
- Sample Compatibility:
- Suitable for human serum, plasma, and various biological fluids.
Principle
The assay utilizes a Sandwich-ELISA technique for the specific and quantitative measurement of CERK. Below is the workflow:
- Pre-Coated Plate:
- Microelisa stripplate wells are pre-coated with an antibody specific to CERK.
- Sample and Standard Addition:
- Standards and samples are added to the wells, allowing CERK in the sample to bind to the immobilized antibody.
- HRP-Conjugated Detection:
- A Horseradish Peroxidase (HRP)-conjugated antibody specific to CERK is added, forming a sandwich complex.
- Washing Step:
- Free and unbound components are washed away to reduce background interference.
- Substrate Reaction:
- TMB substrate solution reacts with HRP, producing a blue color in wells with CERK.
- Stop Reaction and Measurement:
- A stop solution is added, changing the color from blue to yellow. Optical density (OD) is measured at 450 nm using a spectrophotometer.
- Quantification:
- CERK concentrations are calculated by comparing OD values to a standard curve.
Key Features
- High Sensitivity and Specificity:
- Accurately detects low levels of CERK with minimal cross-reactivity.
- Wide Sample Compatibility:
- Suitable for serum, plasma, culture media, and other biological fluids.
- Quantitative Results:
- Provides precise measurement of CERK concentrations using a standard curve.
- Ease of Use:
- Pre-coated plates and ready-to-use reagents simplify the workflow.
- Reproducibility:
- Ensures consistent and reliable results across multiple experiments.
Kit Components
- Pre-coated Microelisa stripplate.
- CERK standards for standard curve generation.
- HRP-conjugated CERK detection antibody.
- TMB substrate solution.
- Stop solution.
- Wash buffer.
- Sample diluent.
- Instruction manual.
Applications
- Lipid Signaling Research:
- Explore CERK’s role in ceramide and sphingolipid metabolism.
- Metabolic Studies:
- Investigate CERK as a biomarker in lipid-related metabolic disorders.
- Cellular Signaling Pathways:
- Study CERK’s involvement in cell signaling and inflammatory responses.
- Drug Development:
- Assess the impact of therapeutic interventions targeting CERK-related pathways.
- Disease Research:
- Monitor CERK levels in diseases such as cancer, diabetes, and neurodegenerative conditions.
Advantages
- High Accuracy:
- Provides precise and reproducible quantification of CERK.
- Convenience:
- Ready-to-use reagents simplify preparation and assay execution.
- Versatility:
- Compatible with various biological sample types.
- Reliable:
- Delivers consistent results for robust data interpretation.
Assay Protocol Summary
- Add standards or samples to the pre-coated wells.
- Incubate with HRP-conjugated CERK antibody.
- Wash to remove unbound components.
- Add TMB substrate to develop color.
- Stop the reaction and measure OD at 450 nm.
- Calculate CERK concentrations using the standard curve.
Storage and Stability
- Store all kit components at 2–8°C to maintain reagent integrity.
- Avoid repeated freeze-thaw cycles to ensure assay reliability.
The Human Ceramide Kinase (CERK) ELISA Kit is a valuable tool for quantifying CERK in biological samples. Its high sensitivity, specificity, and user-friendly design make it an essential resource for lipid metabolism research, cellular signaling studies, and the development of CERK-targeted therapeutics.